BioXcel Therapeutics, Inc. Warrant Down Round Feature Increase Decrease In Equity Amount1
BioXcel Therapeutics, Inc. (BTAI) reported Warrant Down Round Feature Increase Decrease In Equity Amount1 of $59.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Shareholders' Equity
us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1 · last filed 2026-03-27
- BioXcel Therapeutics, Inc. warrant down round feature increase decrease in equity amount1 for fiscal 2024 was $59.00K, a 76.77% decline from fiscal 2023.
- BioXcel Therapeutics, Inc. warrant down round feature increase decrease in equity amount1 for fiscal 2023 was $254.00K.
| Period end | Warrant Down Round Feature Increase Decrease In Equity Amount1 12 month |
|---|---|
| 2024-12-31 | $59.00K 10-K · filed 2026-03-27 |
| 2023-12-31 | $254.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |